Goodrx Holdings, Inc. ( (GDRX) ) has released its Q3 earnings. Here is a breakdown of the information Goodrx Holdings, Inc. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
GoodRx Holdings, Inc. is a prominent U.S. platform focused on medication savings, connecting consumers, healthcare professionals, and pharmaceutical entities to facilitate affordable prescription access. In its third-quarter 2025 earnings report, GoodRx demonstrated a stable financial performance, maintaining its revenue and adjusted EBITDA expectations for the year while raising its outlook for pharma manufacturer solutions revenue growth. The company reported a revenue of $196 million, with a net income of $1.1 million and an adjusted EBITDA of $66.3 million. Despite a decline in prescription transactions and subscription revenue, GoodRx saw a significant 54% increase in pharma manufacturer solutions revenue, highlighting its expanding market penetration. Looking forward, GoodRx remains committed to its strategic priorities, focusing on profitable growth and long-term value creation, while navigating the dynamic healthcare landscape.